Atavistik Bio News and Activities

View the org chart displaying its 16 main executives

Most searched biographies at Atavistik Bio

• Bryan Stuart, Chief Executive Officer and Director
• Jeff Goater, Director
• Shaq Vayda, Director

Popular executive movements at Atavistik Bio

• Mohammad Hirmand has joined the company as Director  (posted on September 26 2024).
• Paul Bruno has joined the company as Chief Business Officer  (posted on August 13 2024).

Create your alert
to follow the executive moves at Atavistik Bio.

Atavistik Bio has 2,338 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).

Popular M&A news in Biotechnology

• The new name of Garuda Therapeutics is Stratus Therapeutics. (posted on May 12 2025).
• Jade Biosciences and Aerovate Therapeutics have announced they will merge  (posted on April 30 2025)..
• Deepull has just announced a $50 Million fundraising (posted on April 29 2025).

Popular contacts in Biotechnology

• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group
• Deepika Verma - Associate Director of Data Science and Digitalization at Wheeler Bio
• Kristina Burow - Director at Scholar Rock

Learn more about the Biotechnology industry

Press releases by Atavistik Bio

• Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics - Atavistik Bio
• Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - Atavistik Bio
• Atavistik Bio Announces Nomination of Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor - Atavistik Bio
• Atavistik Bio Appoints Oncology Clinical Development Leader Mohammad Hirmand, M.D. to Board of Directors - Atavistik Bio
• Atavistik Bio Strengthens Leadership Team with Appointment of Paul Bruno, Ph.D. as Chief Business Officer - Atavistik Bio
• Atavistik Bio Raises Additional $40 Million to Advance Precision Allosteric Small Molecule Therapeutics - Atavistik Bio
• Atavistik Bio Appoints Bryan Stuart as Chief Executive Officer - Atavistik Bio
• The Search to Unlock Protein-Metabolite Interactions: An interview with Jared Rutter, Ph.D. and Kevin Hicks, Ph.D. About Atavistik Bio’s Foundational Technology and the Inspiration - Atavistik Bio
• Atavistik Bio Announces Publication in Science by Co-Founder Jared Rutter Describing Foundational Technology for its Atavistik Metabolite-Protein Screening (AMPS) Platform - Atavistik Bio
• Atavistik Bio Announces Collaboration with Plex Research to Enrich the Informatics Capabilities of its AMPS Platform and Accelerate the Discovery of Novel Small Molecule Therapeutics - Atavistik Bio
• View more press releases Close

Social media about Atavistik Bio

• Atavistik Bio on Wikipedia, Google News & Yahoo Finance
• Atavistik Bio on LinkedIn, Twitter & YouTube